Masters to expand access to Chagas disease treatment

The UK firm Masters has signed an exclusive deal with Brazil's state-owned Pharmaceutical Laboratory of Pernambuco (Lafepe) for the global distribution of benznidazole for the treatment of Chagas disease.

The UK firm Masters has signed an exclusive deal with Brazil's state-owned Pharmaceutical Laboratory of Pernambuco (Lafepe) for the global distribution of benznidazole for the treatment of Chagas disease.

Chagas disease kills around 14,000 people each year in Latin America alone and 70% of patients suffering from this neglected...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Drug Pricing

More from Scrip